NeuroSolv Therapeutics Developing New Therapy to Treat Spinal Cord Injury, Partners With AscellaHealth to Bring Therapy to Market

Jul 11, 2023

DUBLIN--(BUSINESS WIRE)--In partnership with AscellaHealth, NeuroSolv Therapeutics is seeking to expand the clinical trial development programme and accelerate regulatory approval procedures to optimise the prospect of bringing Perineline™ to market.

To read more, click here.

Cookie Policy

Read our Privacy Policy to learn more. We use cookies to help us better understand how our customers interact with our website. Read our Privacy Policy to learn more.